HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

fluorodopa F 18

Subscribe to New Research on fluorodopa F 18

RN given refers to (L)-isomer

Also Known As:

(18)F-dopa; 18F-FDOPA; 2-fluoro-5-hydroxytyrosine; 3,4-dihydroxy-6-fluorophenylalanine; 3-(2-fluoro-(18)F-4,5-dihydroxyphenyl)-L-alanine; 6-(18F)fluoro-L-3,4-dihydroxyphenylalanine; 6-(18F)fluoro-L-DOPA; 6-fluoro-DOPA; 6-fluorodopa; fluorodopa F 18, (18)F-labeled cpd

Networked: 105 relevant articles (4 outcomes, 20 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Piccardo, Arnoldo: 7 articles (12/2015 - 01/2012)
2.	Czernin, Johannes: 7 articles (10/2014 - 06/2006)
3.	Brooks, David J: 7 articles (08/2012 - 03/2002)
4.	Chen, Wei: 6 articles (07/2014 - 06/2006)
5.	Morana, Giovanni: 5 articles (12/2015 - 03/2014)
6.	Fanti, Stefano: 5 articles (06/2014 - 01/2010)
7.	Piccini, Paola: 5 articles (08/2012 - 03/2002)
8.	Puntoni, Matteo: 4 articles (12/2015 - 01/2012)
9.	Conte, Massimo: 4 articles (09/2015 - 01/2012)
10.	Imperiale, Alessio: 4 articles (08/2015 - 08/2012)

Related Diseases

1.	Parkinson Disease (Parkinson's Disease) 12/01/2002 - "The clinically affected PARK6 subjects had a similar 85% reduction in posterior dorsal putamen (18)F-dopa uptake to a group of idiopathic Parkinson's disease patients matched for clinical disease severity and duration but showed significantly greater involvement of head of caudate and anterior putamen. " 05/01/2003 - "Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study." 06/01/2015 - "Brain (18)F-DOPA PET and cognition in de novo Parkinson's disease." 03/01/2006 - "We have used MR segmented inversion recovery ratio imaging (SIRRIM) of the substantia nigra pars compacta to detect and correlate nigral signal change in idiopathic Parkinson's disease (PD) and parkin patients with striatal (18)F-dopa uptake. " 09/01/2005 - "Fluorodopa F 18 positron emission tomography and the progression of Parkinson disease."
2.	Neoplasms (Cancer) 10/01/2009 - "To localize tumors causing catecholamine excess, (18)F-DOPA PET is superior to (123)I-MIBG scintigraphy and CT/MRI." 10/01/2014 - "(18)F-DOPA uptake by the basal ganglia was present (SUV(mean), 2.6 ± 0.7) but did not affect tumor visualization. " 10/01/2014 - "Thirty (18)F-FET and (18)F-DOPA PET/CT scans were obtained before surgery or biopsy in 27 patients with high clinical suspicion for primary or recurrent HGG (5 primary, 22 recurrent tumors). " 05/01/2014 - "The (18)F-DOPA uptake pattern was heterogeneous in all positive scans (9/13), revealing metabolic heterogeneities within each tumor. " 05/01/2014 - "Correlations between the degree and extent of (18)F-DOPA uptake, MR imaging tumor characteristics, and histologic results were investigated. "
3.	Hypoglycemia (Reactive Hypoglycemia) 01/01/2011 - "A Japanese boy who presented with symptomatic hyperinsulinemic hypoglycemia at the age of 2 days and spontaneous resolution at 1 year and 10 months was subjected to mutational analysis and repeated (18)F-DOPA PET scans. " 06/01/2012 - "We describe a woman with biochemically confirmed post-RYGB hypoglycemia who showed diffuse uptake of the (11)C-HTP and (18)F-DOPA tracers in the entire pancreas. " 06/01/2012 - "We present a patient with post-RYGB hypoglycemia who underwent (11)C-HTP and (18)F-DOPA PET scintigraphy for diagnostic purposes and to evaluate the effect of additional laparoscopic adjustable banding of the pouch as a surgical therapy for this disorder. " 01/01/2010 - "OBJECTIVE, PATIENTS, AND DESIGN: The objective of this study was to review our experience with 18F-FDOPA PET imaging in six consecutive patients with hyperinsulinemic hypoglycemia (HH) (four solitary insulinomas, one diffuse beta-cell hyperplasia, one malignant insulinoma). " 08/01/2015 - "Dynamic 18F-FDOPA PET Findings After Carbidopa Premedication in 2 Adult Patients With Insulinoma-Related Hyperinsulinemic Hypoglycemia."
4.	Pheochromocytoma 02/01/2014 - "In the assessment of pheochromocytoma, the combination of (18)F-DOPA PET with MRI is superior to MRI-alone. " 09/01/2015 - "The aim of this retrospective study was to evaluate role of (18)F-DOPA PET/CT and (131)I-MIBG planar scintigraphy in patients with pheochromocytoma. " 09/01/2015 - "Role of (18)F-DOPA PET/CT and (131)I-MIBG planar scintigraphy in evaluating patients with pheochromocytoma." 02/01/2014 - "(18)F-DOPA PET/MRI may yield a higher diagnostic confidence for the detection of pheochromocytoma than (18)F-DOPA PET/CT." 02/01/2014 - "(18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas."
5.	Parkinsonian Disorders (Parkinsonism) 02/23/2011 - "After 1 year, animals showed a significant recovery of the parkinsonism (San Sebastian et al., 2007) and PET studies revealed a larger striatal (18)F-DOPA uptake in the CBCA-grafted striatum compared to that receiving Tyrode. " 01/01/1989 - "Cyanide-induced parkinsonism: clinical, MRI, and 6-fluorodopa PET studies." 12/01/2014 - "The short acquisition protocol, the various indications in oncology of 18F-FDOPA and the high quality of PET images are in favor of this technique in daily clinical practice for the improvement of diagnosis of parkinsonian syndromes. " 12/01/2014 - "18F-FDOPA PET has been historically used for the evaluation of parkinsonian syndromes in research settings. " 12/01/2014 - "18F-FDOPA PET for the diagnosis of parkinsonian syndromes."

Related Drugs and Biologics

1.	Dopamine (Intropin)
2.	Carbidopa (Lodosyn)
3.	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
4.	Levodopa (L Dopa)
5.	Somatostatin Receptors (Somatostatin Receptor)
6.	3-Iodobenzylguanidine (Iobenguane)
7.	Radiopharmaceuticals
8.	Dopamine Agonists (Dopamine Agonist)
9.	Serotonin (5 Hydroxytryptamine)
10.	Manganese

Related Therapies and Procedures

1.	Aftercare (After-Treatment)
2.	Premedication
3.	Drug Therapy (Chemotherapy)